I think you are spot on here. Grapefruit is putting so much emphasis on the regulatory and compliance aspects and this will end up being a great strength. With Hourglass they are doing the learnings that Pharma is not willing to do yet. Once Hourglass proves itself and the Fed's approve nationwide this will be a rocketship. One that a Pharma will likely want to acquire. Bring on 2021 I say. Holding on to my shares.